RxDoctor Payments Data

Joel Mittleman

Nephrology · Beverly Hills, CANPI 1346211794

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 31.0% of the total. Reporting peaked in 2019 at $1,215 and has fallen 78.5% since, to $261 in 2023.

$1,759in general payments, 2019–2025

Across 93 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$545
  • Outset Medical Inc$261
  • AstraZeneca$168
  • Mallinckrodt Enterprises LLC$133
  • Daiichi Sankyo Inc.$122
  • Otsuka America Pharmaceutical, Inc.$92
  • plus $438 from 13 others

What the payments were for

  • Food & beverage$1,759100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,759 in reported general payments places this provider in the 60th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California →

Other nephrology in Beverly Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →